Announcements
- Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
- Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
- Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
- Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
More ▼
Key statistics
On Thursday, Prestige Consumer Healthcare Inc (PBV:FRA) closed at 63.50, -7.30% below its 52-week high of 68.50, set on Mar 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 63.50 |
---|---|
High | 63.50 |
Low | 63.50 |
Bid | -- |
Offer | -- |
Previous close | 63.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.65m |
Free float | 49.05m |
P/E (TTM) | -- |
Market cap | 3.38bn USD |
EPS (TTM) | -1.64 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 15:00 BST.
More ▼